1.
Integrated Network Pharmacology, ADMET Profiling, and Molecular Docking Investigation of Losartan and Its Active Metabolite Against Angiotensin-Related Target. IJPRMP [Internet]. 2026 Oct. 30 [cited 2026 Nov. 1];2(5):76-82. Available from: https://informativejournals.com/journal/index.php/Journal_Medicinal_Plants/article/view/328